Nirmatrelvir (Paxlovid) Resistance (3.5-fold)    2
Nirmatrelvir (Paxlovid) Resistance (233-fold)    2
Sotrovimab Resistance (>192-fold)                2
Sotrovimab Resistance (>100-fold)                2
